PBMs, Pricing, and Policy: The Fight for Fair Access to GLP-1s
Age and Comorbidities Drive RSV Hospitalization Rates in Older Adults
Pembrolizumab in Combination With Platinum-, Fluoropyrimidine-Based Chemotherapy Receives FDA Approval for GEJ
FDA Grants Orphan Drug Designation to Exidavnemab for Multiple System Atrophy